Skip to:

HIV/AIDS

Recent Scholarly Publications

Records 24 / 119

Income Shocks and HIV in Africa

June 2015

We examine how variation in local economic conditions has shaped the AIDS epidemic in Africa.

Girls' education and HIV risk: Evidence from Uganda

June 2013

Uganda is widely viewed as a public health success for curtailing its HIV/AIDS epidemic in the early 1990s.

Global Impact of Antiretroviral Therapy-Associated Diarrhea

December 2012

The cost-effectiveness of preexposure prophylaxis for HIV prevention in men who have sex with men in the United States

December 2012

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users

December 2012

HIV Development Assistance and Adult Mortality in Africa

December 2012

Context  The effect of global health initiatives on population health is uncertain.

Characteristics of U.S. Emergency Departments That Offer Routine Human Immunodeficiency Virus Screening.

July 2012

Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for ukraine

December 2011

Abstract BACKGROUND: Injection drug use (IDU) and heterosexual virus transmission both contribute to the growing mixed HIV epidemics in Eastern Europe and Central Asia.

Expected value information improves financial risk taking across the adult life span

December 2011

Abstract When making decisions, individuals must often compensate for cognitive limitations, particularly in the face of advanced age.

Inferring model parameters in network-based disease simulation

December 2011

Abstract Many models of infectious disease ignore the underlying contact structure through which the disease spreads.

Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention

December 2011

Abstract We estimated the effectiveness and cost-effectiveness of changes in concurrent sexual partnerships in reducing the spread of HIV in sub-Saharan Africa.

Determinants of the cost of health services used by veterans with HIV

December 2011

BACKGROUND: The effect of adherence, treatment failure, and comorbidities on the cost of HIV care is not well understood.

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA

December 2011

OBJECTIVE: Acute HIV infection often causes influenza-like illness (ILI) and is associated with high infectivity.

The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results

December 2011

BACKGROUND: The prime-boost HIV vaccine regimen used in the recent RV144 trial resulted in modest efficacy of 31% over 3.5 years, but was substantially higher in the first year post-vaccination.

HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779

December 2011

The mechanism by which strictly CCR5 using HIV-1 clade C variants exacerbate disease progression in absence of coreceptor switch is not clearly known.

A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop

December 2011

Identification of vulnerability in the HIV-1 envelope (Env) will aid in Env-based vaccine design.

Characterization of circulating HIV-1 env genes in plasma of two antiretroviral naïve slow progressing patients with broad neutralizing antibody response with evidence of recombination

September 2011

In the present study, we investigated genetic divergence between complete autologous HIV-1 env genes amplified directly from plasma of two anti-retroviral naïve, slow progressing Indian patients...

Genetic Conservation in gp36 Transmembrane Sequences of Indian HIV Type 2 Isolates

May 2011

Abstract HIV-2 group A is predominant in different parts of the world, especially Africa, Portugal, Spain, France, the United Kingdom, the United States, Korea, and India.

Cost-effectiveness of a Modestly Effective HIV Vaccine in the United States

April 2011

BACKGROUND: The recent RV144 clinical trial showed that an ALVAC/AIDSVAX prime-boost  HIV vaccine regimen may confer partial immunity in recipients and reduce transmission by 31%.

Effect of Treatment Interruption and Intensification of Antiretroviral Therapy on Health-related Quality of Life in Patients with Advanced HIV

March 2011

Background. The effect of antiretroviral therapy (ART) interruption or intensification on health-related quality of life (HRQoL) in advanced HIV patients is unknown. Objective.

Effectiveness and Cost Effectiveness of Expanding Harm Reduction Programs and HIV Antiretroviral Therapy in a Mixed HIV epidemic: An Analysis for Ukraine

March 2011

Background Injection drug use (IDU) and heterosexual virus transmission both contribute to the growing mixed HIV epidemics in Eastern Europe and Central Asia.

Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-drug Resistant HIV Infection from the OPTIMA trial

March 2011

Background Guidance is needed on best medical management for advanced HIV disease with multidrug resistance (MDR) and limited retreatment options.

Effectiveness and Cost-effectiveness of HIV Antiretroviral Regimens Recommended in the World Health Organization’s Guidelines for Resource-limited Settings

January 2011

Objective: The World Health Organization (WHO) recently changed its first-line antiretroviral treatment guidelines in resource-limited settings.